NCT02550327 2021-06-22
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Completed
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Pancreatic Adenocarcinoma × Interleukin 1 Receptor Antagonist Protein × Clear all